Cargando…
The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy
Autores principales: | Suresh, Raagini, Murase, Jenny E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172478/ https://www.ncbi.nlm.nih.gov/pubmed/30306123 http://dx.doi.org/10.1016/j.jdcr.2018.08.027 |
Ejemplares similares
-
Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD)(,,)()
por: Raffi, Jodie, et al.
Publicado: (2019) -
Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()
por: Raffi, Jodie, et al.
Publicado: (2019) -
Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series
por: Arnold, Kathryn A., et al.
Publicado: (2018) -
Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
por: Deng, Lin, et al.
Publicado: (2022) -
The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series
por: Chen, Jiaoquan, et al.
Publicado: (2023)